These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 31638183)
21. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349 [TBL] [Abstract][Full Text] [Related]
22. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer. Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083 [TBL] [Abstract][Full Text] [Related]
23. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b. Fang Q; Chen X; Zhi X Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794 [TBL] [Abstract][Full Text] [Related]
24. Molecular changes consistent with increased proliferation and invasion are common in rectal cancer. Hughes R; Parry J; Beynon J; Jenkins G Clin Transl Oncol; 2011 Oct; 13(10):753-9. PubMed ID: 21975339 [TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Wang M; Han D; Yuan Z; Hu H; Zhao Z; Yang R; Jin Y; Zou C; Chen Y; Wang G; Gao X; Wang X Cell Death Dis; 2018 Nov; 9(12):1149. PubMed ID: 30451820 [TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Han D; Gao X; Wang M; Qiao Y; Xu Y; Yang J; Dong N; He J; Sun Q; Lv G; Xu C; Tao J; Ma N Oncotarget; 2016 Apr; 7(16):22159-73. PubMed ID: 26989025 [TBL] [Abstract][Full Text] [Related]
27. LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer. Li N; Yu J; Luo A; Tang Y; Liu W; Wang S; Liu Y; Song Y; Fang H; Chen B; Qi S; Lu N; Yu Z; Li Y; Liu Z; Jin J J Cell Biochem; 2019 Apr; 120(4):5207-5217. PubMed ID: 30320451 [TBL] [Abstract][Full Text] [Related]
28. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer. Flanagan L; Kehoe J; Fay J; Bacon O; Lindner AU; Kay EW; Deasy J; McNamara DA; Prehn JH Radiat Oncol; 2015 Jun; 10():131. PubMed ID: 26071313 [TBL] [Abstract][Full Text] [Related]
29. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
30. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis. Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901 [TBL] [Abstract][Full Text] [Related]
31. Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis. Ak Aksoy S; Tunca B; Erçelik M; Tezcan G; Ozturk E; Cecener G; Ugras N; Yilmazlar T; Yerci O Mol Biol Rep; 2022 Dec; 49(12):11243-11253. PubMed ID: 35794508 [TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway. Yu Z; Zhang C; Wang H; Xing J; Gong H; Yu E; Zhang W; Zhang X; Cao G; Fu C Cancer Lett; 2014 Oct; 353(2):182-93. PubMed ID: 25088576 [TBL] [Abstract][Full Text] [Related]
33. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933 [TBL] [Abstract][Full Text] [Related]
34. The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis. Sun F; Liang W; Qian J Mol Med Rep; 2019 Oct; 20(4):3583-3596. PubMed ID: 31432188 [TBL] [Abstract][Full Text] [Related]
35. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Wang J; Ye C; Liu J; Hu Y Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711 [TBL] [Abstract][Full Text] [Related]
36. UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. Zhang L; Cao X; Zhang L; Zhang X; Sheng H; Tao K Cancer Chemother Pharmacol; 2016 Mar; 77(3):629-34. PubMed ID: 26851957 [TBL] [Abstract][Full Text] [Related]
37. Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. Xue M; Chen W; Li X J Cancer Res Clin Oncol; 2016 Jul; 142(7):1407-19. PubMed ID: 26341664 [TBL] [Abstract][Full Text] [Related]
38. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway. Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766 [TBL] [Abstract][Full Text] [Related]
39. Chemosensitivity analysis and study of gene resistance on tumors and cancer stem cell isolates from patients with colorectal cancer. Garza-Treviño EN; Martínez-Rodríguez HG; Delgado-González P; Solís-Coronado O; Ortíz-Lopez R; Soto-Domínguez A; Treviño VM; Padilla-Rivas GR; Islas-Cisneros JF; Quiroz-Reyes AG; Said-Fernández SL Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396431 [TBL] [Abstract][Full Text] [Related]
40. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study. Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]